Expression of monocyte chemoattractant protein-1 cDNA in vascular smooth muscle cells: induction of the synthetic phenotype: a possible clue to SMC differentiation in the process of atherogenesis.
In the arterial wall, smooth muscle cells (SMC) normally exist in a quiescent, differentiated state, representing the contractile phenotype. During the development of atherosclerosis SMC change towards the synthetic phenotype going along with proliferation, chemotactic response and increased monocyte binding. Expression of monocyte chemoattractant protein-1 (MCP-1), a potent chemoattractant for monocytes, has been shown to be among the earliest events in atherogenesis. We investigated the effect of MCP-1 on differentiated and dedifferentiated SMC. Differentiation of SMC was induced using Matrigel as a matrix for cultivation. MCP-1 was expressed in SMC by means of a recombinant adenovirus. Expression of MCP-1 led to dedifferentiation of SMC as demonstrated by induction of cytokeratin 18, a marker for the synthetic phenotype. Concurrently, migration was only detectable in MCP-1 expressing cells, whereas SMC infected with a control virus, coding for the nuclear-targeted lacZ gene showed no migration. The expression of intercellular adhesion molecule-1 (ICAM-1) could be demonstrated in synthetic SMC and was induced after infection of differentiated cells with recombinant adenovirus, coding for MCP-1 (AdMCP-1). Expression of ICAM-1 was associated with a tenfold higher monocyte binding compared to lacZ infected cells. Our data suggest that MCP-1 plays an important role for SMC in the functional switch from the contractile to the synthetic phenotype in the course of atherogenesis.
Denger
S
S
Department of Cardiology, University of Heidelberg, Germany.
Jahn
L
L
Wende
P
P
Watson
L
L
Gerber
S H
SH
Kübler
W
W
Kreuzer
J
J
D000256:Adenoviridae; D001161:Arteriosclerosis / Q000473:pathology / Q000503:physiopathology* / Q000821:virology; D001483:Base Sequence; D002448:Cell Adhesion; D018929:Cell Culture Techniques; D002454:Cell Differentiation / Q000235:genetics / Q000502:physiology; D018932:Chemokine CCL2 / Q000235:genetics*; D018076:DNA, Complementary / Q000032:analysis*; D005786:Gene Expression Regulation / Q000502:physiology; D005819:Genetic Markers; D006801:Humans; D015151:Immunoblotting; D007150:Immunohistochemistry; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D007633:Keratins / Q000032:analysis; D008969:Molecular Sequence Data; D009000:Monocytes / Q000378:metabolism; D009131:Muscle, Smooth, Vascular / Q000737:chemistry* / Q000821:virology; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012680:Sensitivity and Specificity
D018932:Chemokine CCL2; D018076:DNA, Complementary; D005819:Genetic Markers; D018799:Intercellular Adhesion Molecule-1; D007633:Keratins